المؤلفون: Kazimierz Groen, Fredrik H. Schjesvold, Bronno van der Holt, Mark-David Levin, Maarten R. Seefat, Markus Hansson, Maria B.L. Leys, Josien C. Regelink, Anders Waage, Damian Szatkowski, Per Axelsson, Trung Hieu Do, Asta Svirskaite, Ellen van der Spek, Einar Haukas, Dorota Knut-Bojanowska, Paula F. Ypma, Cecilie H. Blimark, Ulf-Henrik Mellqvist, Niels W.C.J. van de Donk, Pieter Sonneveld, Anja Klostergaard, Annette J. Vangsted, Niels Abildgaard, Sonja Zweegman

المصدر: HemaSphere, Vol 7, Iss 9, p e940 (2023)

مصطلحات موضوعية: Diseases of the blood and blood-forming organs, RC633-647.5

وصف الملف: electronic resource

العلاقة: http://journals.lww.com/10.1097/HS9.0000000000000940Test; https://doaj.org/toc/2572-9241Test

الوصول الحر: https://doaj.org/article/0e36d499e0794a4290aa550a76896055Test

المؤلفون: Sonja Zweegman, Claudia A.M. Stege, Einar Haukas, Fredrik H. Schjesvold, Mark-David Levin, Anders Waage, Rineke B.L. Leys, Saskia K. Klein, Damian Szatkowski, Per Axelsson, Trung Hieu Do, Dorota Knut-Bojanowska, Ellen van der Spek, Asta Svirskaite, Anja Klostergaard, Morten Salomo, Celine Blimark, Paula F. Ypma, Ulf-Henrik Mellqvist, Pino J. Poddighe, Marian Stevens-Kroef, Niels W.C.J. van de Donk, Pieter Sonneveld, Markus Hansson, Bronno van der Holt, Niels Abildgaard

المصدر: Haematologica, Vol 105, Iss 12 (2020)

مصطلحات موضوعية: Diseases of the blood and blood-forming organs, RC633-647.5

وصف الملف: electronic resource

العلاقة: https://haematologica.org/article/view/9655Test; https://doaj.org/toc/0390-6078Test; https://doaj.org/toc/1592-8721Test

الوصول الحر: https://doaj.org/article/ae2dab95ebb94eb98d88468acc0873bcTest

المؤلفون: Sonja Zweegman, Zweegman, Claudia A M Stege, A, Haukås, Einar, Schjesvold, Fredrik H, Mark-David Levin, Levin, Waage, Anders, Rineke B L Leys, B, Saskia K Klein, K, Szatkowski, Damian Lukasz, Per Axelsson, Axelsson, Trung Hieu Do, Hieu, Dorota Knut-Bojanowska, Knut-Bojanowska, Ellen van der Spek, van, Asta Svirskaite, Svirskaite, Anja Klostergaard, Klostergaard, Morten Salomo, Salomo, Celine Blimark, Blimark, Paula F Ypma, F, Ulf-Henrik Mellqvist, Mellqvist, Pino J Poddighe, J, Marian Stevens-Kroef, Stevens-Kroef, Niels W C J van de Donk, W, Pieter Sonneveld, Sonneveld, Markus Hansson, Hansson, Bronno van der Holt, van, Niels Abildgaard, Abildgaard

الإتاحة: https://hdl.handle.net/11250/2733197Test

المؤلفون: Ellen van der Spek, Morten Salomo, Damian L. Szatkowski, Einar Haukås, Paula F. Ypma, Per Axelsson, Saskia K. Klein, Pino J Poddighe, Sonja Zweegman, Fredrik Schjesvold, Mark-David Levin, Marian Stevens-Kroef, Asta Svirskaite, Trung Hieu Do, Pieter Sonneveld, Markus Hansson, Claudia A.M. Stege, Dorota Knut-Bojanowska, Celine Blimark, Anja Klostergaard, Rineke B. L. Leys, Niels Abildgaard, Niels W.C.J. van de Donk, Bronno van der Holt, Anders Waage, Ulf-Henrik Mellqvist

المساهمون: Hematology

المصدر: Haematologica, 105, 12, pp. 2879-82
Zweegman, S, Stege, C A M, Haukas, E, Schjesvold, F H, Levin, M-D, Waage, A, Leys, R B L, Klein, S K, Szatkowski, D, Axelsson, P, Hieu Do, T, Knut-Bojanowska, D, van der Spek, E, Svirskaite, A, Klostergaard, A, Salomo, M, Blimark, C, Ypma, P F, Mellqvist, U-H, Poddighe, P J, Stevens-Kroef, M, van de Donk, N W C J, Sonneveld, P, Hansson, M, van der Holt, B & Abildgaard, N 2020, ' Ixazomib-Thalidomide-low dose dexamethasone induction followed by maintenance therapy with ixazomib or placebo in newly diagnosed multiple myeloma patients not eligible for autologous stem cell transplantation; results from the randomized phase II HOVON-126/NMSG 21.13 trial ', Haematologica, vol. 105, no. 12, pp. 2879-2882 . https://doi.org/10.3324/haematol.2019.240374Test
Haematologica, 105(12), 2879-2882. Ferrata Storti Foundation
Haematologica, 105, 2879-82
Haematologica
Sonja Zweegman, Z, Claudia A M Stege, A M S, Einar Haukas, H, Fredrik H Schjesvold, H S, Mark-David Levin, L, Anders Waage, W, Rineke B L Leys, B L L, Saskia K Klein, K K, Damian Szatkowski, S, Per Axelsson, A, Trung Hieu Do, H D, Dorota Knut-Bojanowska, K-B, Ellen van der Spek, V D S, Asta Svirskaite, S, Klostergaard, A, Morten Salomo, S, Celine Blimark, B, Paula F Ypma, F Y, Ulf-Henrik Mellqvist, M, Pino J Poddighe, J P, Marian Stevens-Kroef, S-K, Niels W C J van de Donk, W C J V D D, Pieter Sonneveld, S, Markus Hansson, H, Bronno van der Holt, V D H & Niels Abildgaard, A 2020, ' Ixazomib-Thalidomide-low dose dexamethasone induction followed by maintenance therapy with ixazomib or placebo in newly diagnosed multiple myeloma patients not eligible for autologous stem cell transplantation; results from the randomized phase II HOVON-126/NMSG 21.13 trial ', Haematologica, vol. 105, no. 12, pp. 2879-2882 . https://doi.org/10.3324/haematol.2019.240374Test

مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, medicine.medical_treatment, Cancer development and immune defence Radboud Institute for Molecular Life Sciences [Radboudumc 2], Hematology, Hematopoietic stem cell transplantation, medicine.disease, Ixazomib, Clinical trial, Thalidomide, Transplantation, chemistry.chemical_compound, Autologous stem-cell transplantation, chemistry, Maintenance therapy, Internal medicine, medicine, Letters to the Editor, business, Multiple myeloma, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0355ddccdcad64c6d512a5e716350e5dTest
https://hdl.handle.net/2066/229254Test

المؤلفون: Meletios A Dimopoulos, Francesca Gay, Fredrik Schjesvold, Meral Beksac, Roman Hajek, Katja Christina Weisel, Hartmut Goldschmidt, Vladimir Maisnar, Philippe Moreau, Chang Ki Min, Agnieszka Pluta, Wee-Joo Chng, Martin Kaiser, Sonja Zweegman, Maria-Victoria Mateos, Andrew Spencer, Shinsuke Iida, Gareth Morgan, Kaveri Suryanarayan, Zhaoyang Teng, Tomas Skacel, Antonio Palumbo, Ajeeta B Dash, Neeraj Gupta, Richard Labotka, S Vincent Rajkumar, Daniel Bar, Alfredo Basso, Dorotea Fantl, Simon He, Neomi Horvath, Cindy Lee, Phillip Rowlings, Kerry Taylor, Tara Cochrane, Fiona Kwok, Sundreswran Ramanathan, Hermine Agis, Niklas Zojer, Alain Kentos, Fritz Offner, Jan Van Droogenbroeck, Ka Lung Wu, Angelo Maiolino, Gracia Martinez, Karla Zanella, Marcelo Capra, Sérgio Araújo, Evzen Gregora, Ludek Pour, Vlastimil Scudla, Ivan Spicka, Niels Abildgaard, Niels Andersen, Bo Amdi Jensen, Carsten Helleberg, Torben Plesner, Morten Salomo, Asta Svirskaite, Richard Delarue, Igor Blau, Aneta Schieferdecker, Veronica Teleanu, Markus Munder, Christoph Röllig, Han-Juergen Salwender, Stephan Fuhrmann, Katja Weisel, Jan Duerig, Matthias Zeis, Stefan Klein, Peter Reimer, Christian Schmidt, Christof Scheid, Karin Mayer, Martin Hoffmann, Markus Sosada, Athanasios Dimopoulos, Sosana Delimpasi, Mary-Christine Kyrtsonis, Achilleas Anagnostopoulos, Zsolt Nagy, Árpád Illés, Miklós Egyed, Zita Borbényi, Gabor Mikala, Najib Dally, Netanel Horowitz, Odit Gutwein, Anatoly Nemets, Iuliana Vaxman, Olga Shvetz, Svetlana Trestman, Rosa Ruchlemer, Arnon Nagler, Tamar Tadmor, Ory Rouvio, Meir Preis, Michele Cavo, Luca De Rosa, Pellegrino Musto, Anna Cafro, Patrizia Tosi, Massimo Offidani, Alessandro Corso, Giuseppe Rossi, Anna Marina Liberati, Alberto Bosi, Kenshi Suzuki, Chiaki Nakaseko, Takayuki Ishikawa, Morio Matsumoto, Hirokazu Nagai, Kazutaka Sunami, Takaaki Chou, Koichi Akashi, Naoki Takezako, Shotaro Hagiwara, Hyeon Seok Eom, Deog-Yeon Jo, Jin Seok Kim, Jae Hoon Lee, Sung Soo Yoon, Dok Hyun Yoon, Kihyun Kim, Mark-David Levin, Edo Vellenga, Monique Minnema, Anders Waage, Einar Haukås, Sebastian Grosicki, Andrzej Pluta, Tadeusz Robak, Herlander Marques, Rui Bergantim, Fernando Campilho, Wee Joo Chng, Yeow Tee Goh, Andrew McDonald, Bernado Rapoport, Miguel Angel Álvarez Rivas, Felipe De Arriba de La Fuente, Yolanda González Montes, Jesus Martin Sanchez, Maria Victoria Mateos, Albert Oriol Rocafiguera, Laura Rosinol, Jesús San Miguel, Jaime Pérez de Oteyza, Cristina Encinas, Adrian Alegre-Amor, Ana López-Guía, Per Axelsson, Kristina Carlson, Olga Stromberg, Markus Hansson, Cecile Hveding Blimark, Rouven Mueller, Chih-Cheng Chen, Ta-Chih Liu, Shang-Yi Huang, Po-Nan Wang, Thanyaphong Na Nakorn, Kannadit Prayongratana, Ali Unal, Hakan Goker, Mehmet Sonmez, Sybiryna Korenkova, Aristeidis Chaidos, Heather Oakervee, Hamdi Sati, Reuben Benjamin, Ashutosh Wechalekar, Mamta Garg, Karthik Ramasamy, Gordon Cook, Andrew Chantry, Matthew Jenner, Francis Buadi, Robert Berryman, Murali Janakiram

المساهمون: Takeda Pharmaceutical Company, Dimopoulos MA1, Gay F2, Schjesvold F3, Beksac M4, Hajek R5, Weisel KC6, Goldschmidt H7, Maisnar V8, Moreau P9, Min CK10, Pluta A11, Chng WJ12, Kaiser M13, Zweegman S14, Mateos MV15, Spencer A16, Iida S17, Morgan G18, Suryanarayan K19, Teng Z19, Skacel T19, Palumbo A20, Dash AB19, Gupta N19, Labotka R19, Rajkumar SV21, TOURMALINE-MM3 study group. Bar D, Basso A, Fantl D, He S, Horvath N, Lee C, Rowlings P, Taylor K, Spencer A, Cochrane T, Kwok F, Ramanathan S, Agis H, Zojer N, Kentos A, Offner F, Van Droogenbroeck J, Wu KL, Maiolino A, Martinez G, Zanella K, Capra M, Araújo S, Gregora E, Hajek R, Maisnar V, Pour L, Scudla V, Spicka I, Abildgaard N, Andersen N, Jensen BA, Helleberg C, Plesner T, Salomo M, Svirskaite A, Delarue R, Moreau P, Blau I, Goldschmidt H, Schieferdecker A, Teleanu V, Munder M, Röllig C, Salwender HJ, Fuhrmann S, Weisel K, Duerig J, Zeis M, Klein S, Reimer P, Schmidt C, Scheid C, Mayer K, Hoffmann M, Sosada M, Dimopoulos A, Delimpasi S, Kyrtsonis MC, Anagnostopoulos A, Nagy Z, Illés Á, Egyed M, Borbényi Z, Mikala G, Dally N, Horowitz N, Gutwein O, Nemets A, Vaxman I, Shvetz O, Trestman S, Ruchlemer R, Nagler A, Tadmor T, Rouvio O, Preis M, Gay F, Cavo M, De Rosa L, Musto P, Cafro A, Tosi P, Offidani M, Corso A, Rossi G, Liberati AM, Bosi A, Suzuki K, Iida S, Nakaseko C, Ishikawa T, Matsumoto M, Nagai H, Sunami K, Chou T, Akashi K, Takezako N, Hagiwara S, Eom HS, Jo DY, Kim JS, Lee JH, Min CK, Yoon SS, Yoon DH, Kim K, Zweegman S, Levin MD, Vellenga E, Minnema M, Schjesvold F, Waage A, Haukås E, Grosicki S, Pluta A, Robak T, Marques H, Bergantim R, Campilho F, Chng WJ, Goh YT, McDonald A, Rapoport B, Álvarez Rivas MA, De Arriba de La Fuente F, González Montes Y, Martin Sanchez J, Mateos MV, Oriol Rocafiguera A, Rosinol L, San Miguel J, Pérez de Oteyza J, Encinas C, Alegre-Amor A, López-Guía A, Axelsson P, Carlson K, Stromberg O, Hansson M, Hveding Blimark C, Mueller R, Chen CC, Liu TC, Huang SY, Wang PN, Na Nakorn T, Prayongratana K, Beksac M, Unal A, Goker H, Sonmez M, Korenkova S, Chaidos A, Oakervee H, Sati H, Benjamin R, Wechalekar A, Garg M, Kaiser M, Ramasamy K, Cook G, Chantry A, Jenner M, Buadi F, Berryman R, Janakiram M., Guided Treatment in Optimal Selected Cancer Patients (GUTS), Stem Cell Aging Leukemia and Lymphoma (SALL), CCA - Cancer Treatment and quality of life, CCA - Imaging and biomarkers, CCA - Cancer biology and immunology, Hematology

المصدر: Dimopoulos, M A, Gay, F, Schjesvold, F, Beksac, M, Hajek, R, Weisel, K C, Goldschmidt, H, Maisnar, V, Moreau, P, Min, C K, Pluta, A, Chng, W-J, Kaiser, M, Zweegman, S, Mateos, M-V, Spencer, A, Iida, S, Morgan, G, Suryanarayan, K, Teng, Z, Skacel, T, Palumbo, A, Dash, A B, Gupta, N, Labotka, R, Rajkumar, S V, Abildgaard, N & TOURMALINE-MM3 study group 2019, ' Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3) : a double-blind, randomised, placebo-controlled phase 3 trial ', Lancet, vol. 393, no. 10168, pp. 253-264 . https://doi.org/10.1016/S0140-6736Test(18)33003-4
Dimopoulos, M A, Gay, F, Schjesvold, F, Beksac, M, Hajek, R, Weisel, K C, Goldschmidt, H, Maisnar, V, Moreau, P, Min, C K, Pluta, A, Chng, W J, Kaiser, M, Zweegman, S, Mateos, M V, Spencer, A, Iida, S, Morgan, G, Suryanarayan, K, Teng, Z, Skacel, T, Palumbo, A, Dash, A B, Gupta, N, Labotka, R, Rajkumar, S V, Kwok, F & TOURMALINE-MM3 study group 2019, ' Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3) : a double-blind, randomised, placebo-controlled phase 3 trial ', The Lancet, vol. 393, no. 10168, pp. 253-264 . https://doi.org/10.1016/S0140-6736Test(18)33003-4
Digital.CSIC. Repositorio Institucional del CSIC
instname
Lancet, 393(10168), 253. Elsevier Limited
LANCET, 393(10168), 253-264. ELSEVIER SCIENCE INC
The Lancet, 393(10168), 253-264. Elsevier Limited

مصطلحات موضوعية: Male, Time Factors, DIAGNOSED MULTIPLE-MYELOMA, Clinical Trial, Phase III, Administration, Oral, 030204 cardiovascular system & hematology, Ixazomib, chemistry.chemical_compound, 0302 clinical medicine, Autologous stem-cell transplantation, Maintenance therapy, Clinical endpoint, 030212 general & internal medicine, Non-U.S. Gov't, Boron Compounds/administration & dosage, IMPROVES SURVIVAL, INDUCTION, Research Support, Non-U.S. Gov't, General Medicine, CHEMOTHERAPY, Middle Aged, Clinical Trial, DEXAMETHASONE, Antineoplastic Agents/administration & dosage, Multicenter Study, Treatment Outcome, Administration, Randomized Controlled Trial, Disease Progression, Female, Multiple Myeloma, Autologous, Boron Compounds, Oral, medicine.medical_specialty, Glycine, Multiple Myeloma/drug therapy, BORTEZOMIB, Antineoplastic Agents, Placebo, Research Support, Transplantation, Autologous, 03 medical and health sciences, Phase III, Double-Blind Method, Internal medicine, medicine, Journal Article, Humans, THALIDOMIDE, Transplantation, business.industry, Clinical trial, LENALIDOMIDE MAINTENANCE, Regimen, chemistry, autologous stem cell transplantation, multiple myeloma, Ixazomib, business, HIGH-DOSE THERAPY, Glycine/administration & dosage, Stem Cell Transplantation

وصف الملف: image/pdf; application/pdf; STAMPA

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0de353f2eca3bce4266841424f74a30cTest
http://hdl.handle.net/2318/1732833Test

المؤلفون: Maria B.L. Leijs, Pieter Sonneveld, Bronno van der Holt, Marian Stevens-Kroef, Per Axelsson, Niels Abildgaard, Markus Hansson, Pino Poddighe, Saskia K. Klein, Anders Waage, Sonja Zweegman, Dorota Knut-Bojanovska, Asta Svirskaite, Einar Haukås, Mark-David Levin, Fredrik Schjesvold, Damian L. Szatkowski, Niels W.C.J. van de Donk, Trung Hieu Do, Claudia A.M. Stege, Ellen van der Spek

المصدر: Zweegman, S, Schjesvold, F H, van der Holt, B, Levin, M-D, Stege, C A M, Waage, A, Leijs, M B L, Klein, S K, Szatkowski, D L, Axelsson, P, Do, T H, Knut-Bojanovska, D, van der Spek, E, Svirskaite, A, Poddighe, P, Stevens-Kroef, M, Hansson, M, van de Donk, N W C J, Haukas, E, Sonneveld, P & Abildgaard, N 2018, ' Ixazomib-Thalidomide-Low Dose Dexamethasone (ITd) Induction Followed By Maintenance Therapy with Ixazomib or Placebo in Newly Diagnosed Multiple Myeloma Patients Not Eligible for Autologous Stem Cell Transplantation; Results from the Randomized Phase II HOVON-126/Nmsg 2113 Trial ', Blood, vol. 132, no. Suppl. 1 . https://doi.org/10.1182/blood-2018-99-111650Test
Zweegman, S, Schjesvold, F H, van der Holt, B, Levin, M-D, Stege, C A M, Waage, A, Leijs, M B L, Klein, S K, Szatkowski, D L, Axelsson, P, Do, T H, Knut-Bojanovska, D, van der Spek, E, Svirskaite, A, Poddighe, P, Stevens-Kroef, M, Hansson, M, van de Donk, N W C J, Haukas, E, Sonneveld, P & Abildgaard, N 2018, ' Ixazomib-Thalidomide-Low Dose Dexamethasone (ITd) Induction Followed By Maintenance Therapy with Ixazomib or Placebo in Newly Diagnosed Multiple Myeloma Patients Not Eligible for Autologous Stem Cell Transplantation; Results from the Randomized Phase II HOVON-126/Nmsg 21#13 Trial ', Blood, vol. 132, no. Suppl. 1, pp. 800-800 . https://doi.org/10.1182/blood-2018-99-111650Test

مصطلحات موضوعية: medicine.medical_specialty, Randomization, business.industry, Immunology, Cell Biology, Hematology, Placebo, Biochemistry, Ixazomib, Thalidomide, Transplantation, 03 medical and health sciences, Regimen, chemistry.chemical_compound, 0302 clinical medicine, chemistry, Maintenance therapy, 030220 oncology & carcinogenesis, Internal medicine, medicine, Progression-free survival, business, 030215 immunology, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ceeda16a8771971fe347d1cbf1046e5Test
https://portal.findresearcher.sdu.dk/da/publications/e77b2b7e-45e9-46e3-8538-b5ea1c4d970dTest

المؤلفون: Ulf Christian Frølund, Birgitte Preiss, Mette K. Andersen, Carsten Helleberg, Kristian Thidemann Andersen, Eigil Kjeldsen, Niels Frost Andersen, Per Trøllund Pedersen, Peter Gimsing, Annette Juul Vangsted, Sissel Helm-Petersen, Niels Abildgaard, Asta Svirskaite, TW Klausen

المصدر: Andersen, K T, Klausen, T W, Abildgaard, N, Andersen, M K, Andersen, N F, Frølund, U C, Helleberg, C, Kjeldsen, E, Pedersen, P, Helm-Petersen, S, Svirskaite, A, Preiss, B S, Gimsing, P & Vangsted, A J 2017, ' Causes of early death in multiple myeloma patients treated with high-dose therapy followed by autologous stem cell transplantation : A study based on the nationwide Danish Multiple Myeloma Registry ', American Journal of Hematology, vol. 92, no. 10, pp. E611-E614 . https://doi.org/10.1002/ajh.24857Test
Thidemann Andersen, K, Klausen, T W, Abildgaard, N, Klarskov Andersen, M, Frost Andersen, N, Christian Frølund, U, Helleberg, C, Kjeldsen, E, Pedersen, P, Helm-Petersen, S, Svirskaite, A, Preiss, B S, Gimsing, P & Juul Vangsted, A 2017, ' Causes of early death in multiple myeloma patients treated with high-dose therapy followed by autologous stem cell transplantation : A study based on the nationwide Danish Multiple Myeloma Registry ', American Journal of Hematology, pp. E611-E614 . https://doi.org/10.1002/ajh.24857Test
Andersen, K T, Klausen, T, Abildgaard, N, Andersen, M K, Andersen, N F, Frølund, U C, Helleberg, C, Kjeldsen, E, Pedersen, P T, Helm-Petersen, S, Svirskaite, A, Preiss, B, Gimsing, P & Vangsted, A J 2017, ' Causes of early death in multiple myeloma patients treated with high-dose therapy followed by autologous stem cell transplantation : A study based on the nationwide Danish Multiple Myeloma Registry ', American Journal of Hematology, vol. 92, no. 10, pp. E611–E614 . https://doi.org/10.1002/ajh.24857Test

مصطلحات موضوعية: Oncology, Adult, Male, medicine.medical_specialty, Letter, Cyclophosphamide, Denmark, Dexamethasone, Disease-Free Survival, Danish, Bortezomib, 03 medical and health sciences, 0302 clinical medicine, Autologous stem-cell transplantation, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Registries, Autografts, Survival rate, Multiple myeloma, Aged, business.industry, Hematology, Middle Aged, medicine.disease, language.human_language, Thalidomide, Survival Rate, 030220 oncology & carcinogenesis, Immunology, language, Female, business, Multiple Myeloma, 030215 immunology, medicine.drug, Stem Cell Transplantation

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4f0940b9cf42abf788680a3ba339f44Test
https://vbn.aau.dk/da/publications/a4bc6dd0-9a1d-4f8c-a05e-3e6534069472Test

المؤلفون: Hans Erik Johnsen, Alexander Schmitz, Julie Støve Bødker, Sonneveld, P., Hofste Op Bruinink, D., Holt, B., Velden, V. H. J., Abildgaard, N., Ahlberg, L., Andersen, N., Andreasson, B., Brandefors, L., Christiansen, H. B., Faxoe, S., Fransson, C., Friestad, M., Gregersen, H., Hammerlund, Y., Hansson, M., Haukaas, E., Hector, M., Helleberg, C., Holst, M., Jönsson, A. K., Karlsson, V., Klostergaard, A., Kjær, S., Lauri, B., Lenhoff, S., Lonn, I., Myhr, E., Pedersen, B. H., Renna, R., Sjøgren, T. V., Asta Svirskaite, Szatkowski, D. L., Vangsted, S., Waage, A., Schjesvold, F. H., U-H, Mellqvist, Helle Høholt, Louise Hvilshøj Madsen, Henning Sand Christensen, Rasmus Brøndum, Martin Bøgsted, Karen Dybkaer

المصدر: Aalborg University
Johnsen, H E, Schmitz, A, Bødker, J S, Sonneveld, P, Hofste op Bruinink, D, van der Holt, B, van der Velden, V H J, Abildgaard, N, Ahlberg, L, Andersen, N, Andreasson, B, Brandefors, L, Christiansen, H B, Faxoe, S, Fransson, C, Friestad, M, Gregersen, H, Hammerlund, Y, Hansson, M, Haukaas, E, Hector, M, Helleberg, C, Holst, M, Jönsson, A K, Karlsson, V, Klostergaard, A, Kjær, S, Lauri, B, Lenhoff, S, Lonn, I, Myhr, E, Pedersen, B H, Renna, R, Sjøgren, T V, Svirskaite, A, Szatkowski, D L, Vangsted, S, Waage, A, Schjesvold, F H, Mellqvist, U-H, Høholt, H, Madsen, L H, Christensen, H S, Brøndum, R F, Bøgsted, M & Dybkær, K 2018, ' Minimal Residual Disease (MRD) follow up of MM patients obtaining stringent complete remission (sCR) in the NMSG/EMN02 clinical trial – defining sCR numbers and prediction of disease progression by multiparametric flow cytometry (MFC). ', Haematologica, vol. 103, no. S1, BA6, pp. 13 . < http://www.emn2018.com/doc/Abstract-book.pdfTest >

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::16f7414171447361f275e257d55088a8Test
https://vbn.aau.dk/en/publications/2e93ef3e-a0c1-42fd-91fc-9ee0616eb58bTest